Redpoint Bio to Present at the Mid-Atlantic Capital (MAC) Conference

EWING, N.J.--(BUSINESS WIRE)--Redpoint Bio Corporation (OTCBB: RPBC), a company developing compounds to improve the taste of pharmaceutical, food and beverage products, today announced that Chief Executive Officer, Ray Salemme, Ph.D., will be presenting an overview of Redpoint Bio at the Mid-Atlantic Capital (MAC) Conference on Wednesday, December 3, 2008 at the Pennsylvania Convention Center in Philadelphia, PA. Dr. Salemme’s presentation will take place at 11:27 am in the Life Science Room. The event will not be webcast.

The MAC Conference brings together individual entrepreneurs in all stages of development. Emerging companies in areas such as technology and life sciences have the opportunity to showcase individual talents and seek out the experienced resources and expert services they need. Entrepreneurs will also find the investors, venture capitalists, and private equity funds that seek out strong potential.

About Redpoint Bio Corporation

Redpoint Bio is leveraging recent discoveries in the molecular biology of taste to discover and develop novel taste enhancers and aversive taste blockers for the food, beverage and pharmaceutical industries. Redpoint Bio's food and beverage program is focused on identifying flavor enhancers that improve the taste of existing ingredients, reduce the need for excess sugar and salt, and contribute to the development of healthier, better-tasting foods and beverages. The pharmaceutical program uses a biochemical approach aimed at suppressing the bitterness of medicines, which has the potential to expand the range of formulation options and increase patient compliance. For more information, please visit the Company's website at www.redpointbio.com.

About the Mid-Atlantic Capital Alliance

The Mid-Atlantic Capital Alliance is the catalyst organization that connects people, ideas and capital at all stages of company growth and investment and promotes the Greater Philadelphia region as one of North America’s top private equity markets—from venture to buyout. For more information, please visit the Company's website at http://www.macalliance.com/.

Safe Harbor Statement

In addition to historical facts or statements of current condition, this press release contains forward-looking statements within the meaning of the "Safe Harbor" provisions of The Private Securities Litigation Reform Act of 1995. Forward-looking statements provide the Company's current expectations or forecasts of future events. The Company's performance and financial results could differ materially from those reflected in these forward-looking statements due to, among other factors, uncertainty inherent in the discovery phase of technological development, any efforts by third parties to invalidate or limit any patents, the marketplace acceptance of its products, the decisions of regulatory authorities, the results of clinical trials and general financial, economic, regulatory and political conditions affecting the food and beverage, biotechnology and pharmaceutical industries generally. Given these risks and uncertainties, any or all of these forward-looking statements may prove to be incorrect. The Company undertakes no obligation to update publicly any forward-looking statement.